These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 29212549)

  • 1. Hypertriglyceridemia and atherosclerosis.
    Peng J; Luo F; Ruan G; Peng R; Li X
    Lipids Health Dis; 2017 Dec; 16(1):233. PubMed ID: 29212549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder: a pilot cross-sectional study.
    Iida K; Tani S; Atsumi W; Yagi T; Kawauchi K; Matsumoto N; Hirayama A
    Coron Artery Dis; 2017 Nov; 28(7):577-587. PubMed ID: 28692480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypertriglyceridemia for prevention of atherosclerotic cardiovascular disease.
    Brinton EA
    Cardiol Clin; 2015 May; 33(2):309-23. PubMed ID: 25939302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of triglycerides in atherosclerosis.
    Talayero BG; Sacks FM
    Curr Cardiol Rep; 2011 Dec; 13(6):544-52. PubMed ID: 21968696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.
    Sandesara PB; Virani SS; Fazio S; Shapiro MD
    Endocr Rev; 2019 Apr; 40(2):537-557. PubMed ID: 30312399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies.
    Tada H; Nohara A; Kawashiri MA
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical science relating atherosclerotic diseases and hypertriglyceridemia].
    Fujioka Y
    Nihon Rinsho; 2013 Sep; 71(9):1546-51. PubMed ID: 24205712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
    Dallinga-Thie GM; Kroon J; Borén J; Chapman MJ
    Curr Cardiol Rep; 2016 Jul; 18(7):67. PubMed ID: 27216847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglycerides and Residual Atherosclerotic Risk.
    Raposeiras-Roubin S; Rosselló X; Oliva B; Fernández-Friera L; Mendiguren JM; Andrés V; Bueno H; Sanz J; Martínez de Vega V; Abu-Assi E; Iñiguez A; Fernández-Ortiz A; Ibáñez B; Fuster V
    J Am Coll Cardiol; 2021 Jun; 77(24):3031-3041. PubMed ID: 34140107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of hypertriglyceridemia].
    Imano H; Iso H
    Nihon Rinsho; 2013 Sep; 71(9):1528-35. PubMed ID: 24205710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of potentially atherogenic triglyceride-rich lipoprotein particles].
    Alaupovic P; Blankenhorn DH
    Klin Wochenschr; 1990; 68 Suppl 22():38-42. PubMed ID: 2087077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.
    Hussain A; Ballantyne CM; Saeed A; Virani SS
    Curr Atheroscler Rep; 2020 Jun; 22(7):25. PubMed ID: 32494924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes and Consequences of Hypertriglyceridemia.
    Packard CJ; Boren J; Taskinen MR
    Front Endocrinol (Lausanne); 2020; 11():252. PubMed ID: 32477261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial hypertriglyceridemia as a coronary risk factor.
    Borén J; Matikainen N; Adiels M; Taskinen MR
    Clin Chim Acta; 2014 Apr; 431():131-42. PubMed ID: 24508990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated LDL Triglycerides and Atherosclerotic Risk.
    Balling M; Afzal S; Davey Smith G; Varbo A; Langsted A; Kamstrup PR; Nordestgaard BG
    J Am Coll Cardiol; 2023 Jan; 81(2):136-152. PubMed ID: 36631208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Links Between Hypertriglyceridemia and Atherogenesis.
    Peng X; Wu H
    Curr Atheroscler Rep; 2022 May; 24(5):297-306. PubMed ID: 35274230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very-Low-Density Lipoproteins.
    Lawler PR; Akinkuolie AO; Harada P; Glynn RJ; Chasman DI; Ridker PM; Mora S
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29223956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertriglyceridemia: danger for the arteries].
    Chanu B
    Presse Med; 1999 Nov; 28(36):2011-7. PubMed ID: 10599270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction.
    Liu QK
    J Clin Lipidol; 2021; 15(4):556-568. PubMed ID: 34172393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.